Kiniksa Pharmaceuticals International Plc (KNSA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Kiniksa Pharmaceuticals International Plc-Aktie (KNSA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.01% 214.27	202.13	180.85	156.80	137.78
Cost Of Revenue	0.71% 20.80	20.95	20.26	18.60	17.87
Selling, General, and Administrative	61.15	-	-	-	-
Depreciation and Amortization	0.21% 0.468	0.467	0.384	0.358	0.345
Operating Income/Loss	48.05% 29.27	19.77	24.02	20.16	13.27
Income/Loss From Continuing Operations Before Tax	40.45% 32.68	23.27	27.16	22.88	15.56
Income Tax Expense/Benefit, Deferred	44.14% 4.523	3.138	4.227	2.644	2.993
Income Tax Expense/Benefit	11.23% 10.09	9.07	8.722	5.045	7.026
Net Income/Loss	59.11% 22.59	14.20	18.43	17.83	8.539
Basic Average Shares	12,755% 76.52	0.5952	74.71	73.44	72.65
Diluted Average Shares	8,560% 82.41	0.9517	80.04	77.94	76.15
Basic Earnings Per Share	57.89% 0.30	0.19	0.25	0.24	0.12
Diluted Earnings Per Share	50.00% 0.27	0.18	0.23	0.23	0.11